Compare DYN & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYN | SHOO |
|---|---|---|
| Founded | 1984 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.4B |
| IPO Year | 2020 | 1996 |
| Metric | DYN | SHOO |
|---|---|---|
| Price | $17.97 | $33.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $37.00 | ★ $42.43 |
| AVG Volume (30 Days) | ★ 2.3M | 1.4M |
| Earning Date | 03-02-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.63 |
| Revenue | N/A | ★ $2,534,109,000.00 |
| Revenue This Year | N/A | $12.39 |
| Revenue Next Year | N/A | $5.90 |
| P/E Ratio | ★ N/A | $50.39 |
| Revenue Growth | N/A | ★ 11.00 |
| 52 Week Low | $7.01 | $19.05 |
| 52 Week High | $25.00 | $46.88 |
| Indicator | DYN | SHOO |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 43.34 |
| Support Level | $16.34 | $31.85 |
| Resistance Level | $20.08 | $35.98 |
| Average True Range (ATR) | 1.16 | 1.41 |
| MACD | 0.08 | 0.22 |
| Stochastic Oscillator | 62.93 | 45.83 |
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.